Physician

Anastasios P Saliaris, M.D.

According to 2025 Medicare claims, Anastasios Saliaris, M.D. (NPI: 1982673885) practices cardiac electrophysiology in the Billings, MT market, with the plurality of this provider's patient population coming from Yellowstone, MT. This provider's primary affiliated billing organization is SCL HEALTH MEDICAL GROUP - BILLINGS LLC (NPI: 1508289703; TIN: 464056262) and primary practice location at 59101-0127. Saliaris is affiliated with the Rocky Mountain Accountable Health Network, Inc (ACO ID: A2217), Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), Collaborative ACO 30, LLC (ACO ID: A5483), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Saliaris' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 3,641 traditional Medicare patients, billed 11,976 HCPCS/CPT codes, and received $314,224 in Medicare payments. The top billing code was 93295 (Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days). Part D data shows 611 prescription claims across 166 beneficiaries totaling $165,392 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 45 records totaling $2,323. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $138,979 to $314,224. Similarly, Part D prescription costs have moved sharply higher in recent years, from $20,880 to $165,392. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,430	2,451	$138,979
2016	1,569	2,899	$128,042
2017	3,158	7,219	$219,317
2018	4,242	9,947	$246,526
2019	4,498	11,231	$259,650
2020	3,310	8,190	$205,531
2021	3,532	9,062	$239,021
2022	3,710	9,858	$222,123
2023	2,934	8,656	$269,050
2024	3,641	11,976	$314,224

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	71	250	$20,880
2016	105	384	$44,739
2017	116	389	$50,611
2018	139	533	$91,497
2019	134	567	$107,089
2020	142	515	$126,408
2021	132	404	$104,587
2022	158	553	$140,145
2023	145	603	$206,032
2024	166	611	$165,392

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93295	Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days	232	561	$25
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	553	1,400	$20
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	785	1,957	$15
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	716	835	$11
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	2,450	4,207	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	117	5,590	$104,670
Xarelto	Rivaroxaban	39	2,490	$44,536
Metoprolol Succinate	Metoprolol Succinate	134	10,172	$1,868
Amiodarone Hcl	Amiodarone Hcl	82	6,465	$893
Propranolol Hcl Er	Propranolol Hcl	20	1,140	$738

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	45	$2,323	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anastasios P. Saliaris, M.D.?

Tedicare shows public-source Medicare data for Anastasios P. Saliaris, M.D. (NPI 1982673885), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anastasios P. Saliaris, M.D. have ACO affiliation data?

Anastasios P. Saliaris, M.D. is shown with ACO affiliation data for Rocky Mountain Accountable Health Network, Inc (MSSP, ACO ID A2217), Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), Collaborative ACO 30, LLC (MSSP, ACO ID A5483), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Anastasios P. Saliaris, M.D.?

Anastasios P. Saliaris, M.D. is linked to SCL HEALTH MEDICAL GROUP - BILLINGS LLC (billing NPI 1508289703) in the available physician profile data.

Does Anastasios P. Saliaris, M.D. have Open Payments data?

Anastasios P. Saliaris, M.D. has 45 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.